Modag
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics.
Modag operates in biotechnology, therapeutics based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2013.
Modag is positioned in biotechnology, therapeutics, a segment that rewards a clear, focused offering.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Series_A stage.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $12M.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2013 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $12,000,000 |
Website: www.modag.net
Sign in to view the contact information we hold for Modag.
Create a free account
Create a free account